Plain-English translation of NCT06928259 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is comparing two medications used to treat hepatitis C—SOF/VEL and GLE/PIB—to understand how they interact with other medications patients may be taking. Researchers want to see whether one medication causes more problems with other drugs than the other, and whether doctors have to change doses or switch medications more often with one treatment versus the other.
Many people with hepatitis C take multiple medications for other health conditions, and these medications can interact with each other. While guidelines recommend checking for these interactions, real-world practice shows this doesn't always happen. This study wants to find out whether these drug interactions actually cause real problems for patients in everyday treatment.
You likely qualify if…
You likely don't qualify if…
You would not need to visit a clinic or take any new medications. Instead, researchers would review your existing medical records from your hepatitis C treatment to see what other medications you were taking and whether your doctor made any changes to them during your treatment. This is a study of real-world treatment records, so participation mainly involves giving permission for your medical information to be used in the research.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Spain